Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform Program (SDS-GPS Program)

NCT06999954 is registered in ClinicalTrials.gov with Shwachman-Diamond Syndrome Alliance Inc as lead sponsor.

NCT NCT06999954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06999954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform Program (SDS-GPS Program)
Lead sponsor
Shwachman-Diamond Syndrome Alliance Inc
Phase
Observational
Overall status
Recruiting
Start date
February 7, 2024
Completion date
December 31, 2088
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive delay, mild, congenital neutropenia, dnajc21 gene mutation, efl1 gene mutation, elane, exocrine pancreatic insufficiency, heme malignancy, ibmf, immune deficiency, inherited bmf syndrome, inherited bone marrow failure, inherited cancer syndrome, inherited cancer-predisposing syndrome, inherited immunodeficiency diseases, myelodysplastic syndromes, neutropenia chronic benign, neutropenia other, neutropenia, severe chronic, pancytopenia, ribosome alteration, ribosomopathy, sbds gene mutation, sds, shwachman syndrome, shwachman-diamond syndrome, srp54 gene mutation, whim